← Open Payments lookup

JENNIFER MIRON: Open Payments

NPI 1336486752 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,257 in 90 payments from 16 companies in 2025. Trend: 2023 $1,780 · 2024 $1,917 · 2025 $2,257

Food & beverage: $2,173Education: $84
CompanyPaymentsAmount
ABBVIE INC.35$843
Ardelyx, Inc.12$307
Janssen Biotech, Inc.11$306
Regeneron Healthcare Solutions, Inc.5$146
Aimmune Therapeutics, Inc.5$118
Madrigal Pharmaceuticals3$111
Takeda Pharmaceuticals U.S.A., Inc.3$94
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$72
EVOKE PHARMA, INC.3$51
Phathom Pharmaceuticals, Inc.2$43

Products named: RINVOQ, IBSRELA, TREMFYA, SKYRIZI, DUPIXENT, CREON, REZDIFFRA, ZENPEP.

Industry payments across TX — which companies pay providers there.